KAID Health, a Boston MA-based maker of the artificial intelligence-enabled Whole Chart Analysis platform, raised an undisclosed amount in funding.
The round, which brought the total amount to $9M, saw participation from Activate Venture Partners, Martinson Ventures, Boston Millennia Partners, Brandon Hull, and KAID Health’s Board of Directors.
Led by Kevin Agatstein, CEO, KAID Health allows all types of value-based care providers to profit from delivering more informed, coordinated care. Its natural language processing (NLP)-centric Whole Chart Analysis solution integrates all EMR data, including conditions, medications, and lab values, with insights automatically distilled from medical notes. KAID Health uses the latest language models to collect all patient data. The solution identifies the patient care interventions needed for providers to achieve their clinical, financial or operational objectives. In parallel, it extends to payers a comprehensive view of members’ health by combining claims and EMR data.
Today, KAID Health’s technology is used by providers, health systems, academic medical centers and payers to automate a variety of workflows, including coding accuracy, quality measurement, prior authorization support and preoperative assessment.
